S

Smith & Nephew plc
D

SNN

25.045
USD
-0.18
(-0.69%)
Market Closed
Volume
15,585
EPS
2
Div Yield
2.41
P/E
36
Market Cap
10,919,278,737
Related Instruments
    ABBV
    ABBV
    -4.630
    (-2.73%)
    171.713 USD
    AMGN
    AMGN
    -12.22
    (-4.13%)
    289.88 USD
    BMY
    BMY
    -2.270
    (-3.88%)
    56.230 USD
    GILD
    GILD
    -3.715
    (-4.03%)
    88.385 USD
    GSK
    GSK
    -1.020
    (-2.97%)
    33.350 USD
    JNJ
    JNJ
    2.140
    (1.41%)
    155.48 USD
    LLY
    LLY
    -40.34
    (-5.13%)
    749.9 USD
    MRK
    MRK
    -2.050
    (-2.08%)
    99.85 USD
    NVS
    NVS
    -0.350
    (-0.34%)
    103.85 USD
    PFE
    PFE
    -1.225
    (-4.71%)
    25.14 USD
    More
News

Title: Smith & Nephew plc

Sector: Healthcare
Industry: Medical Devices
Smith & Nephew designs, manufactures, and markets orthopedic devices, sports medicine and arthroscopic technologies, and wound-care solutions. Roughly 41% of the U.K.-based firm's revenue comes from orthopedic products, and another 30% is sports medicine and ENT. The remaining 29% of revenue is from the advanced wound therapy segment. Roughly half of Smith & Nephew's total revenue comes from the United States, just over 30% is from other developed markets, and emerging markets account for the remainder.